Johnson & Johnson has announced that Dr. Peter M. Fasolo will retire from his position as executive vice president, chief human resources officer at the end of this year, following 16 years of leadership and service to the company. Throughout his distinguished career, Dr. Fasolo has worked with the organization’s board of directors and partnered with three company CEOs to shape and grow the company’s human capital strategy.
He will be succeeded in this role by Kristen Mulholland, a strong Credo-based leader who has had an exceptional career with depth and breadth across the company’s innovative medicine and MedTech sectors, managed business unit HR for the company’s global corporate functions, and has led corporate HR services including performance and development and most recently global total rewards.
Mulholland will also be appointed as a member of Johnson & Johnson’s executive committee, effective Oct. 1, 2024. Dr. Fasolo and Mulholland will work together during a transition period until Dr. Fasolo’s retirement at the end of this year.
“Peter has led J&J’s talent strategy for the past 16 years including remarkable leadership through the global pandemic and the separation of our consumer health business,” says Joaquin Duato, chairman and CEO at Johnson & Johnson. “Throughout his career, Peter has always led with two principles in the forefront of every decision and recommendation—our Credo values and a deep responsibility to our employees. He leaves a legacy of strong leaders, deep bench strength, and an inclusive, caring, and patient-focused culture.”
Dr. Fasolo first joined Johnson & Johnson in 2004 as worldwide vice president of human resources in the MedTech segment. HE also served as the company’s chief talent officer with responsibility for executive assessment and development. Dr. Fasolo became J&J’s CHRO and a member of the executive committee in 2010 and has transformed the HR function’s talent and leadership strategy. During his tenure, he strengthened the company’s global DEI outcomes and expanded employee benefits and policies by increasing PTO for leaves such as military, parental, bereavement, volunteerism, and mental well-being, and promoted a healthy workforce.
Mulholland has been with Johnson & Johnson since 2005. Mulholland has held HR leadership positions in the company’s corporate services, global functions, and the MedTech and innovative medicines sectors across commercial and R&D and helped establish the company’s Innovation Centers. In her most recent role as head of HR, global total rewards, and enterprise HR functions at Johnson & Johnson, Mulholland worked closely with the board of directors supporting the compensation and benefits committee and played a key role in the separation of the consumer business to form Kenvue.
“I’m pleased to appoint Kristen to this important role where she will apply her deep business acumen, talent expertise, and Credo-based approach to advance J&J’s culture and operating model,” says Duato. “I’m confident her breadth of experience and strong leadership will ensure Johnson & Johnson’s human capital strategy is poised to deliver the innovative future-ready talent and culture needed to advance healthcare solutions for patients worldwide.”
